Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-000811

SVP, CHIEF LEGAL OFFICER gave up 4,289 shares (to pay taxes)

  • SVP, CHIEF LEGAL OFFICER acquired 7,611 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Snyder Mark Howard · SVP, CHIEF LEGAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-03 Exercise or conversion : show line 1 in the form +7,611 19,291 D
2025-01-03 Shares withheld for taxes : show line 2 in the form −4,289 $47.74 $204,757 15,002 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −7,611 7,611 D
Loading xslF345X05/form4-01062025_100155.xml…